pharmaceutical investing Resverlogix Announces Delay in Filing of Annual Financial Statements, AIF, and MD&A
Resverlogix Announces New Research Highlighting Apabetalone's Potential Benefits in Cardiovascular Disease, Heart Failure, and COVID-19
Resverlogix Cognition Substudy of the BETonMACE Phase 3 Cardiovascular Trial Presented at the International Conference on Alzheimer’s & Parkinson’s Diseases
QIMC Highlights Technical Advisory Role on First Atlas Matane Natural Hydrogen Project Following Quebec Parliamentary Committee Appearance
Gold Resource Corporation Announces Special Shareholder Meeting to Vote on Strategic Merger With Goldgroup Mining
